Survival in β-thalassaemia major in the UK:: data from the UK thalassaemia register

被引：493

作者：

Modell, B ^{[1
]}

Khan, M ^{[1
]}

Darlison, M ^{[1
]}

机构：

[1] Royal Free & UCL, Sch Med, Dept Primary Care & Populat Sci, London N19 3UA, England

来源：

LANCET | 2000年 / 355卷 / 9220期

关键词：

D O I：

10.1016/S0140-6736(00)02357-6

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

About 50% of UK patients with beta-thalassaemia major die before the age of 35 years, mainly because conventional iron-chelation therapy is too burdensome for full adherence. Patients require an idividually-tailored treatment plan incorporating new, more tolerable approaches.

引用

页码：2051 / 2052

页数：2